About Truvic
Truvic is a Healthcare company based in Campbell (United States) founded in 2014, and was acquired by Imperative Care in July 2021. Smart devices for peripheral vascular thrombus management are developed. Truvic has raised $5.89 million across 1 funding round from investors including Imperative Care. Its chief executive, as recorded, is Mike Buck. Truvic offers products and services including Zoom Aspiration Catheters, Prodigy, and Symphony. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is Imperative Care, Inc. Its competitors include Avinger, Pathway Medical Technologies and Intact Vascular; 3 of its 3 listed competitors have raised funding.
Company details
Truvic was founded in 2014 and is headquartered in Campbell, United States. Focus is placed on the medical device sector, where smart devices are developed for managing peripheral vascular diseases. Operations center on enabling single-session thrombus removal without thrombolytics. These devices address thrombus management in peripheral vascular conditions, supporting clinical interventions in the healthcare field.
- Headquarters Campbell, United States
- Stage Acquired
- SectorsHealthcare
- Website truvic.com
- Social LinkedIn YouTube
- Acquired by Imperative Care (Jul 2021)
- Legal Name Imperative Care, Inc.
- Total Equity Funding$5.89M (USD)
in 1 rounds
- Latest Funding Round$5.89M (USD), Series A
Jul 2020
- Investors
- Acquired byImperative Care
(Jul 2021)
Products & Services of Truvic
Truvic offers a comprehensive portfolio of products and services, including Zoom Aspiration Catheters, Prodigy, and Symphony.
Tools for aspiration in stroke procedures to remove clots.
Device for treating acute limb ischemia by clearing blood clots.
System providing real-time feedback for vascular clot removal.
Apps and channels of Truvic
its YouTube channel Imperative Care has 657 subscribers and 28 videos.
Videos from Truvic
The most watched videos on Truvic's YouTube channel, Imperative Care (657 subscribers). Click a video to play it here.
More on Imperative Care.
Funding Insights of Truvic
Truvic has successfully raised a total of $5.89M through 1 strategic funding round. The most recent funding activity was a Series A round of $5.89 million completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.89M
- Total Rounds 1
- Last Round Series A — $5.89M
- First Round $5.89M
(Jul 2020)
All 1 funding rounds of Truvic with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2020 | $5.89M | Series A | – | – | – |
1 investors in total: 1 institutional.
Investors in Truvic
Truvic has secured backing from 1 investor. Prominent investors backing the company include Imperative Care.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Access catheters for neurovascular stroke treatment are provided. | 2015 | imperativecare.com | Campbell, United States |
Investor details for Truvic
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Truvic
20 people are tracked at Truvic (7 in leadership, 13 in team).
| Name | Role | Group |
|---|---|---|
Mike Buck | CEO | Leadership |
Lance Scott | Vice President Marketing | Leadership |
Paul Chen | Senior Director Product Marketing | Leadership |
Julia Fox | Vice President Product Development | Leadership |
Charles Berry | Vice President Of Sales | Leadership |
Emma Lepak | R&d Director | Leadership |
Travis Winslow | Director Of Quality | Leadership |
Hannah Boxerman | Marketing Communications Manager | Team |
Danielle Fakler | R&d Engineer II | Team |
Janell Gallagher | District Sales Manager | Team |
Brandon Awalt | District Sales Manager | Team |
Brian Funk | Senior R&d Engineer | Team |
Anna Mandernach | Principal Engineer R&d | Team |
Mark Spiers | District Sales Manager | Team |
Michael Reardon | Marketing Manager | Team |
Rachel Scheuer | Product Manager | Team |
Vittorio Filippo Olivetti | Sr R&d Project Manager | Team |
Melaina Hissam | Quality Engineer II | Team |
Katharine Treangen (Williams) | Quality System Manager | Team |
Ragni Murugesn | Quality Operations Manager | Team |
Complete people profiles for Truvic
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Truvic
3 dated milestones of Truvic across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Truvic is founded.
- Funding First funding round of $5.9M.
- Exit Acquired by Imperative Care.
Competitors of Truvic
Truvic has 3 listed competitors in our database, 3 of them funded. They include Avinger, Pathway Medical Technologies and Intact Vascular.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| avinger.com | 2007 | Redwood, United States | $170.85M | 80 | Provider of image-guided catheter-based products for peripheral artery disease | |
| pathwaymedical.com | 1998 | Kirkland, United States | $101.93M | 158 | Smart devices are provided to clear peripheral arterial blockages. | |
| intactvascular.com | 2011 | Wayne, United States | $123.4M | 64 | Implants for repairing arteries after angioplasty are developed. |
Detailed competitors of Truvic
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Truvic (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Truvic
Complete news archive for Truvic
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Truvic
Truvic was founded in 2014 and raised its 1st funding round 6 years after it was founded.
Truvic is headquartered in Campbell, United States. It is registered at Campbell, California, United States.
Mike Buck is the CEO of Truvic, as recorded in our data.
Truvic is a funded company, having raised a total of $5.89M across 1 funding round to date. The company's 1st funding round was a Series A of $5.89M, raised on Jul 2020.
Truvic was founded in 2014 and is headquartered in Campbell, United States. Focus is placed on the medical device sector, where smart devices are developed for managing peripheral vascular diseases. Operations center on enabling single-session thrombus removal without thrombolytics. These devices address thrombus management in peripheral vascular conditions, supporting clinical interventions in the healthcare field.
Truvic's top competitors include Avinger, Intact Vascular and Pathway Medical Technologies.
Truvic offers Zoom Aspiration Catheters, Prodigy, and Symphony.
Truvic has 1 investor. Key investors include Imperative Care.
Truvic operates through Imperative Care, Inc..
Yes. Truvic was acquired by Imperative Care in July 2021.